Medtech Firms Battle Tariff Challenges After Year One

One year into facing steep tariffs, medtech companies navigate supply chain disruptions and rising costs from protectionist trade policies. These American firms, hit hard by duties on imported components, shift production to domestic suppliers and explore nearshoring to Mexico, proving tariffs force real change against globalist reliance on cheap foreign labor. Patriots cheer this as a win for US manufacturing sovereignty, cutting dependence on China despite liberal whining about "higher prices. Read more about this...